MEMOLI, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 1.254
EU - Europa 507
AS - Asia 471
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.248
Nazione #
US - Stati Uniti d'America 1.220
SG - Singapore 252
CN - Cina 173
IT - Italia 152
IE - Irlanda 91
FI - Finlandia 79
UA - Ucraina 61
NL - Olanda 56
DE - Germania 34
CA - Canada 33
VN - Vietnam 28
CI - Costa d'Avorio 14
GB - Regno Unito 13
SE - Svezia 13
IN - India 5
BE - Belgio 4
HK - Hong Kong 4
FR - Francia 3
IR - Iran 3
TW - Taiwan 3
AU - Australia 1
EU - Europa 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
RO - Romania 1
TR - Turchia 1
Totale 2.248
Città #
Chandler 248
Singapore 213
Princeton 82
Jacksonville 69
Santa Clara 65
Millbury 64
Boston 59
Nanjing 57
Amsterdam 55
Napoli 42
Ashburn 41
Wilmington 37
Ann Arbor 33
Ottawa 30
Dong Ket 28
Beijing 25
Menlo Park 19
Nanchang 19
Des Moines 14
Houston 13
Jiaxing 13
Hebei 12
Shenyang 12
Woodbridge 11
Norwalk 9
Los Angeles 7
Naples 7
Augusta 6
Dublin 6
Falls Church 6
Greifswald 6
Boardman 5
San Mateo 5
Washington 5
Weifang 5
Changsha 4
Courcelles 4
Orange 4
Casoria 3
Hangzhou 3
Indiana 3
Kronberg 3
Kunming 3
Lanzhou 3
Redwood City 3
Rome 3
San Giorgio Ionico 3
Tianjin 3
Ardabil 2
Bologna 2
Chiaravalle 2
Dallas 2
Monmouth Junction 2
Oliveto Citra 2
Pesaro 2
Seattle 2
Abidjan 1
Bacoli 1
Bari 1
Buxtehude 1
Changchun 1
Clifton 1
Den Haag 1
Edinburgh 1
Frankfurt am Main 1
Greensboro 1
Guangzhou 1
Helsinki 1
Iasi 1
Islington 1
Istanbul 1
Kaohsiung 1
L'aquila 1
Leawood 1
Milan 1
Modugno 1
Nola 1
Nürnberg 1
Ogden 1
Oleggio 1
Pinerolo 1
Pune 1
Ravenna 1
Riomaggiore 1
Round Lake 1
Salerno 1
Santa Maria a Vico 1
Spilamberto 1
Spruce Grove 1
Sydney 1
Taipei 1
Taizhou 1
Tappahannock 1
Toluca 1
Torino 1
Toronto 1
Verona 1
Vimercate 1
Walnut 1
Wenatchee 1
Totale 1.430
Nome #
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial 95
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study. 58
Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data 58
CHANGES OF SERUM ALBUMIN AND C-REACTIVE PROTEIN ARE RELATED TO CHANGES OF INTERLEUKIN 6 RELEASE BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN HEMODIALYSIS PATIENTS TREATED WITH DIFFERENT MEMBRANES. 55
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 53
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients? 51
Body mass index and survival differences in dialysis patients 47
ROLE OF HFR CARTRIDGE IN THE REMOVAL OF MEDIATORS OF INFLAMMATION IN HEMODIALYSIS PATIENTS 47
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. 46
Body composition and cardiovascular risk factors in pretransplant hemodialysis patients 46
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. 46
Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. 46
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD 44
Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. 40
Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients. 38
EARLY IMPAIRMENT OF RENAL HEMODYNAMIC RESERVE IN PATIENTS WITH ASYMPTOMATIC HEART FAILURE IS RESTORED BY ANGIOTENSIN II ANTAGONISM. 37
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 37
Nutritional intervention in a hemodialysis pregnant woman: a case report 35
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis 35
A translational approach to micro-inflammation in End Stage Renal Disease: molecular effects of low levels of Interleukin 6. 34
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients. 34
INTERLEUKIN 2-INDUCED RENAL DYSFUNCTION IN CANCER PATIENTS IS REVERSED BY LOW-DOSE DOPAMINE INFUSION 33
ROLE OF DIFFERENT DIALYSIS MEMBRANES IN THE RELEASE OF INTERLEUKIN 6 SOLUBLE RECEPTOR IN UREMIC PATIENTS. 33
Effects of a diet rich in N-3 polyunsaturated Fatty acids on systemic inflammation in renal transplant recipients. 33
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis. 33
Efficacy of i.v. torasemide in the treatment of acute and chronic high grade renal failure 33
Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data 32
HEMODIALYSIS-RELATED LYMPHOMONONUCLEAR RELEASE OF INTERLEUKIN 12 IN PATIENTS WITH END-STAGE RENAL DISEASE. 30
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 30
Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. 30
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis 30
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase 30
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor 29
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. 29
Acute renal and immunological effects of low-dose cyclosporin in humans. 29
Bicarbonate and calcium kinetics in postdilutional hemodiafiltration. 29
Stop Flow in abdominal and pelvic cancer relapses. 28
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells. 28
Loculated fluid collections evidenced by peritoneal scintigraphy. 28
EFFECT OF MAINTENANCE TREATMENT WITH MYCOPHENOLATE MOFETIL ON CHRONIC INFLAMMATORY STATUS IN PROLIFERATIVE LUPUS NEPHRITIS 28
Comparison of vector and conventional bioelectrical impedance analysis in the optimal dry weight prescription in hemodialysis. 27
Effect of dialysate sodium concentration on interdialytic increase of potassium. 27
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. 27
HEMODIALYSIS-RELATED INDUCTION OF INTERLEUKIN 6 PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS 26
Cytokine production in standard hemodialysis with a new polyethersulfone membrane: a cross-over study. 26
Human plasma ultrafiltrate purification by membrane distillation: process optimisation and evaluation of its possible application on-line 26
RENAL FUNCTIONAL RESERVE. ITS SIGNIFICANCE IN NORMAL AND SALT DEPLETION CONDITION. 24
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. 24
Membrane distillation of human plasma ultrafiltrate and its theoretical applications to haemodialysis techniques. 24
È L’ERITROPOIETINA SEMPRE CITOPROTETTIVA NEI CONFRONTI DELLO STRESS OSSIDATIVO? 24
Extra-natriuretic effects of atrial peptide in humans. 23
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. 23
Cytokine production in haemodialysis. 22
Pleural effusion in peritoneal dialysis: overload or leakage? 22
INFLAMMATORY EFFECTS OF PERITONEAL DIALYSIS. EVIDENCE OF SYSTEMIC MONOCYTE ACTIVATION. 21
Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. 19
Hepatocellular functions of human liver cells in oxygen-permeable membrane device 19
Loop diuretics and renal vasodilators in acute renal failure. 17
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase. 17
The place of loop diuretics in the treatment of acute and chronic renal failure. 17
[The IL-6 soluble receptors in hemodialyzed patients]. 17
Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. 16
Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells. 16
Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor. 16
"Obesity paradox" or a better nutritional status? 16
Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. 16
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. 16
[Guidelines for dialysis. Replacement therapy for acute renal failure in critically ill patients]. 15
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. 15
Human mature adipocytes express albumin and this expression is not regulated by inflammation. 15
Il litio come marker del riassorbimento tubulare prossimale 15
Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphurus homeostasis and progression of atherosclerosis? 14
Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. 14
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion. 14
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. 14
Human galactosylated membrane bioreactor for the long-term maintenance of liver specific functions 14
On the pathophysiology of functional acute renal failure. 13
Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. 12
Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration. 12
The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment. 12
Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. 11
Human hepatocyte functions in a galactosylated membrane bioreactor. 11
Totale 2.326
Categoria #
all - tutte 12.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 0 0 0 0 19 30 8 4 6 6 37 32
2020/2021206 7 13 15 15 17 24 17 3 18 4 43 30
2021/2022428 7 1 0 0 0 6 5 23 80 47 96 163
2022/2023541 86 53 8 46 62 64 0 54 92 56 15 5
2023/2024263 7 45 23 23 14 18 9 22 0 7 74 21
2024/2025294 102 120 8 9 55 0 0 0 0 0 0 0
Totale 2.326